After Twitter's 2023 rebrand into X, hate speech surged on the platform. Social media and video websites like Facebook and ...

Moltbook has been the talk of social media the past week, as its AI agent user base seemingly does everything from conspire ...

It all started with fans — not the kind that cheer or the kind you plug in. Rather, hand fans, the accessories mandatory for all good 19th and early 20th century ladies, seemed like a great idea for ...

BPC-157 hasn't been approved by the FDA. But that hasn't stopped this buzzy drug from gaining traction – and attention from MAHA.

Test system resilience by mapping failure paths and running small experiments that reveal what users experience when things ...

The first dimension is the most fundamental: statistical fidelity. It is not enough for synthetic data to look random. It must behave like real data. This means your distributions, cardinalities, and ...

PSG's director shares his hunt for Barcelona's Pedri, revealing early scouting passion amidst evolving football talent ...

AI toys for kids promise learning and fun, but experts warn of hidden risks to privacy and development. Know the key checks ...

The gray market is awash with BPC-157, a drug hyped as a cure-all, but unapproved by the FDA. Will RFK Jr. change that?

In tech circles, the popularity of Moltbook and OpenClaw (including Clawbot and Moltbot before it) has raised questions over when most consumers will gain easy access to personalised on-device AI ...

No one wants to make costly mistakes when selling a home. Check out these "don'ts" when it comes to putting your home on the market.

Adil Hassan examines the ESG reports of the top 50 Biggest Builders to identify their flood risk strategies, and explores what more we can do to mitigate risk.